Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Vivos Therapeutics (VVOS) Preferred Dividend Payments (2020)

Vivos Therapeutics (VVOS) has disclosed Preferred Dividend Payments for 1 consecutive years, with $1.6 million as the latest value for Q4 2020.

  • On a quarterly basis, Preferred Dividend Payments changed N/A to $1.6 million in Q4 2020 year-over-year; TTM through Dec 2020 was $2.3 million, a N/A change, with the full-year FY2020 number at $2.3 million, up 133.3% from a year prior.
  • Preferred Dividend Payments was $1.6 million for Q4 2020 at Vivos Therapeutics, up from $250000.0 in the prior quarter.
  • In the past five years, Preferred Dividend Payments ranged from a high of $1.6 million in Q4 2020 to a low of $250000.0 in Q1 2020.